Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
about
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzaeActivities of cefoxitin and cefotetan against Mycobacterium fortuitum infections in miceImipenem antagonism of the in vitro activity of piperacillin against Pseudomonas aeruginosa.Imipenem- and meropenem-resistant mutants of Enterobacter cloacae and Proteus rettgeri lack porins.Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.Role of beta-lactam hydrolysis in the mechanism of resistance of a beta-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum beta-lactamsEfficacy of ciprofloxacin in experimental aortic valve endocarditis caused by a multiply beta-lactam-resistant variant of Pseudomonas aeruginosa stably derepressed for beta-lactamase production.In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.Randomized, double-blind comparison of ceftazidime and moxalactam in complicated urinary tract infections.A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients.Molecular evolution, species distribution, and clinical consequences of an endemic aminoglycoside resistance plasmidComparison of azlocillin, ceftizoxime, cefoxitin, and amikacin alone and in combination against Pseudomonas aeruginosa in a neutropenic-site rabbit modelCeftazidime treatment in cystic fibrosis: resistant organisms in sputum and faecesMutation in Serratia marcescens AmpC beta-lactamase producing high-level resistance to ceftazidime and cefpirome.Development of resistance during antibiotic therapy.Clinical significance of beta-lactamase induction and stable derepression in gram-negative rods.Cell surface changes in Pseudomonas aeruginosa PAO4069 in response to treatment with 6-aminopenicillanic acid.Serum bactericidal activity and postantibiotic effect in serum of patients with urinary tract infection receiving high-dose amikacin.Protective effect of amdinocillin against emergence of resistance to ceftazidime in Enterobacter cloacae.Correlation of the effect of beta-lactamase inhibitors on the beta-lactamase in growing cultures of gram-negative bacteria with their effect on the isolated beta-lactamase.Multiply resistant mutants of Enterobacter cloacae selected by beta-lactam antibioticsResistance of Pseudomonas aeruginosa to new beta-lactamase-resistant beta-lactams.Comparison of a beta-lactamase induction test with a test that detects low-frequency resistance to cefotaximeComparison of cefepime, cefpirome, and cefaclidine binding affinities for penicillin-binding proteins in Escherichia coli K-12 and Pseudomonas aeruginosa SC8329.Surgical antimicrobial prophylaxis: principles and guidelines.Recognition and clinical significance of mechanisms of bacterial resistance to beta-lactams.Empiric antimicrobial therapy for febrile granulocytopenic cancer patients. Lessons from four EORTC trials.[A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside]Influence of clindamycin on derepression of beta-lactamases in Enterobacter spp. and Pseudomonas aeruginosaResistance of Pseudomonas aeruginosa mutants with altered control of chromosomal beta-lactamase to piperacillin, ceftazidime, and cefsulodin.Ascorbate as an induction inhibitor of beta-lactamase in a strain of Enterobacter cloacae.Infection with netilmicin resistant Serratia marcescens in a special care baby unit.In vitro antimicrobial activity of aztreonam alone and in combination against bacterial isolates from pediatric patients.Combinations of beta lactam antibiotics.The great cephalosporin wars.Resistant strains of Pseudomonas aeruginosa isolated after exposure to several beta-lactam antibiotics.Plasmid profiles of Acinetobacter and Enterobacter species of hospital origin: restriction endonuclease analysis of plasmid DNA and transformation of Escherichia coli by R plasmids.The influence of clinical use of antibiotics and the sensitivity of strains isolated from postoperative infections--a comparison of nosocomial pathogens with strains isolated from the bacterial flora of patients.Effects of a restrictive antibiotic policy on clinical efficacy of antibiotics and susceptibility patterns of organisms.
P2860
Q33737550-BAADB80D-E828-47D2-9F5A-F23CE095506EQ33737910-A7BA17BC-4696-4C57-9F80-23E9D24D7F9BQ33737945-6071C28B-ECD3-4FA0-A754-E40C73D2FD9EQ33744061-13B50819-4854-4DB5-9A11-79497AB05156Q35248754-D846B5FC-B5D1-44B2-A819-CD9D50B2DAD0Q35570728-BDA3F4BD-58AE-41E1-963B-219023D72E10Q35574922-25F090B4-1BDB-4097-B7A0-A8A6ECC0C3F5Q35640288-BAF66E95-AC79-4A9D-BB95-DB0B4BAE9518Q35640867-749C0529-BF20-4C21-9E41-A51C5F7A5645Q35646344-D7972764-46AE-4F2F-8908-542099D1F48BQ35648068-29D72EC2-6E15-411F-86F8-8F83A12EB857Q35649724-BD2D70B5-C390-4A30-BBB8-2C35BD4936D5Q35759586-F397CDA2-8946-4F2C-9EE3-A4F72E010651Q36242744-7B1CEA9F-3B38-485F-91E0-CE9C58D8507CQ39478020-85AED41D-4139-4C4D-8614-FC99C8AE498DQ39665988-7A80E9A2-6BE6-464B-A665-106EAED7F4E9Q39673650-09826416-B597-44F6-8DED-1D38325119B7Q39819834-DDD0C7AA-1D1A-4F17-AC05-E220DC97BD65Q39828374-7331E319-9941-4871-B335-7A418F1EA4E7Q39832604-05B01F0D-EEF3-470A-9438-3E2B157AB934Q39833500-884AB173-CE9A-4FE4-82FC-AFA0D6366242Q39834931-51EC3672-935B-47A7-A226-571746154F8CQ39849040-B822C278-06AA-4E1A-A671-65B9C0428C52Q39849783-46671BB3-CBC2-487E-B448-0E508ACB9304Q40088008-AE3FBAC5-6571-4BD4-9A7D-E9390958D44DQ40214971-C4D0F2E5-4AF3-40D0-9B72-C5F25EED2C01Q40215884-1F55CB5D-F7A0-4FA9-98C9-B4C74250A25BQ40790815-44108B4C-8FDC-48E8-BA23-E1B944B7A837Q40801783-6B50FB28-1A5E-401A-BAB9-3A9A1665051EQ42091897-D9AEB5E5-5801-40A0-A6D0-52B40BE82996Q42115498-8EE2579F-BDC3-4E32-BCEC-252604CA3683Q42513744-89C97E4B-3C5D-40BD-86C0-B9E13ED00A4CQ42867774-05EE95E5-CC90-4C53-A557-CC7F2C7FEBC5Q42929722-A238C68F-0E5F-42FA-9C35-001791F85683Q43048864-44C62C81-8764-426F-8C66-B2816F7A67A8Q43882306-37227ED9-C683-4C15-94B0-02C515DBBDF4Q45269813-E93F96B1-AF34-4E21-9273-D3B6F87CACC2Q54273489-D34A7919-D8C1-48B4-A609-F951180EE2B8Q54292677-FC1DFC17-4FE0-4553-A6C8-A8E888882E6EQ54322087-7812EEFF-1541-443E-86CD-19A58CF1A194
P2860
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
description
1983 nî lūn-bûn
@nan
1983年の論文
@ja
1983年学术文章
@wuu
1983年学术文章
@zh-cn
1983年学术文章
@zh-hans
1983年学术文章
@zh-my
1983年学术文章
@zh-sg
1983年學術文章
@yue
1983年學術文章
@zh
1983年學術文章
@zh-hant
name
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@en
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@nl
type
label
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@en
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@nl
prefLabel
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@en
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@nl
P356
P1476
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
@en
P2093
Sanders CC
P304
P356
10.1093/INFDIS/147.3.585
P407
P577
1983-03-01T00:00:00Z